scispace - formally typeset
M

Matthew Hedge

Researcher at Wayne State University

Publications -  6
Citations -  270

Matthew Hedge is an academic researcher from Wayne State University. The author has contributed to research in topics: Enzyme & Aromatase. The author has an hindex of 5, co-authored 6 publications receiving 262 citations. Previous affiliations of Matthew Hedge include Detroit Receiving Hospital & University of Minnesota.

Papers
More filters
Journal Article

Identification of a class 3 aldehyde dehydrogenase in human saliva and increased levels of this enzyme, glutathione S-transferases, and DT-diaphorase in the saliva of subjects who continually ingest large quantities of coffee or broccoli

TL;DR: In this article, the salivary content of these enzymes was found to be increased upon daily consumption of relatively large amounts of coffee or broccoli, indicating that these enzymes are abundantly present in the human diet, especially in certain vegetables and fruits.
Journal ArticleDOI

Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.

TL;DR: The results obtained from this investigation are consistent with previous studies which show that aromatase has a hydrophobic pocket in the active site around the C-4 alpha region of androstenedione, and that the free pair of electrons on N, S, or O is not an essential requirement for 4-substituted androstensione derivatives to be effective aromat enzyme inhibitors.
Journal ArticleDOI

Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.

TL;DR: The synthesis and biological evaluation of 4-thiosubstituted derivatives of 1,4-androstadienedione, 4,6-and Frostenedione, and 1,8-androstatrienedione as inhibitors of aromatase were described and were found to be competitive inhibitors and did not produce any time-dependent inactivation of arom atase.
Journal ArticleDOI

Miscellaneous central nervous system intoxicants.

TL;DR: Three classes of therapeutic drugs are focused on, with specific examples in which overdoses require admission to the intensive care unit, including the newer antidepressants, the atypical neuroleptic agents, and selected anticonvulsant drugs.